Induction by Dopamine D1 Receptor Agonist ABT-431 of Dyskinesia Similar to Levodopa in Patients With Parkinson Disease

2001148 citationsJournal Article

Authors

Olivier Rascol · Pharmacochimie et Pharmacologie pour le Développement

John G. Nutt · Université Toulouse III - Paul Sabatier

Olivier Blin · Université Toulouse III - Paul Sabatier

Christopher G. Goetz · Université Toulouse III - Paul Sabatier

Joel M. Trugman · Université Toulouse III - Paul Sabatier

C Soubrouillard · Université Toulouse III - Paul Sabatier

J H Carter

Abstract

Dopamine D(1) agonists can induce a full antiparkinsonian response but do not support previous hypotheses suggesting that D(1) agonists are more or less likely to produce dyskinesias than levodopa.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Botulinum Toxin and Related Neurological Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of Neurology

Volume 58, Issue 2, pp. 249-249

DOI: 10.1001/archneur.58.2.249

Field-Weighted Citation Impact: 5.04